Cannabis stocks rallied Friday following reports that Trump is considering reclassifying marijuana from Schedule I to Schedule III. Bloomberg reported that he discussed the move with industry execs, RFK Jr., and Dr. Oz. This change would group cannabis with drugs like Tylenol with codeine rather than heroin. Tilray jumped 28%, Canopy Growth rose 20%, and Aurora Cannabis was up 15%. SNDL and Cronos also saw double digit gains. A White House official stated no final decision has been made yet.